Cartilage-derived growth factor and antitumor factor: past, present, and future studies.
Suzuki
F
F
Osaka University, 1-1, Yamadaoka, Suita, Osaka, 565-0871, Japan.
D000818:Animals; D000970:Antineoplastic Agents / Q000378:metabolism; D002356:Cartilage / Q000378:metabolism*; D019902:Chondrocytes / Q000378:metabolism; D005109:Extracellular Matrix / Q000235:genetics / Q000378:metabolism; D016222:Fibroblast Growth Factor 2 / Q000378:metabolism; D006133:Growth Substances / Q000378:metabolism*; D006801:Humans; D036341:Intercellular Signaling Peptides and Proteins; D008565:Membrane Proteins; D009389:Neovascularization, Pathologic / Q000378:metabolism; D011506:Proteins / Q000378:metabolism*; D011509:Proteoglycans / Q000378:metabolism; D019715:Tissue Inhibitor of Metalloproteinase-1 / Q000494:pharmacology
D000970:Antineoplastic Agents; D006133:Growth Substances; D036341:Intercellular Signaling Peptides and Proteins; D008565:Membrane Proteins; D011506:Proteins; D011509:Proteoglycans; D019715:Tissue Inhibitor of Metalloproteinase-1; D016222:Fibroblast Growth Factor 2; C068675:CNMD protein, human